Kinase inhibitors for advanced medullary thyroid carcinoma.

ABSTRACT: The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.

SUBMITTER: Schlumberger M 

PROVIDER: S-EPMC3328820 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature